Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
IMAC | BACK | Nov 22, 2024 | 1.08 | -3.57 |
IMAX | IMAX | Nov 22, 2024 | 25.19 | +1.94 |
Immatics | IMTX | Nov 22, 2024 | 7.59 | +0.13 |
Immersion | IMMR | Nov 22, 2024 | 8.88 | +2.54 |
Immix Biopharma | IMMX | Nov 22, 2024 | 1.79 | +6.55 |
ImmuCell | ICCC | Nov 22, 2024 | 3.69 | +0.82 |
Immuneering A | IMRX | Nov 22, 2024 | 2.10 | -0.47 |
Immunic | IMUX | Nov 22, 2024 | 1.10 | -0.90 |
ImmunityBio | IBRX | Nov 22, 2024 | 5.10 | +1.29 |
Immunocore ADR | IMCR | Nov 22, 2024 | 32.28 | +0.50 |
Immunome | IMNM | Nov 22, 2024 | 9.82 | +4.25 |
ImmunoPrecise Antibodies | IPA | Nov 22, 2024 | 0.38 | +7.92 |
Immunovant | IMVT | Nov 22, 2024 | 26.87 | +1.24 |
Immutep ADR | IMMP | Nov 22, 2024 | 1.93 | +4.62 |
Imperial Oil | IMO | Nov 22, 2024 | 77.13 | +0.05 |
Imperial Petroleum | IMPP | Nov 22, 2024 | 3.37 | -0.88 |
Imperial Petroleum A Pref | IMPPP | Nov 22, 2024 | 25.30 | 0.00 |
Impinj | PI | Nov 22, 2024 | 191.04 | +1.46 |
Imunon | IMNN | Nov 22, 2024 | 0.81 | +17.17 |
IN8bio | INAB | Nov 22, 2024 | 0.32 | -0.75 |
Inari Medical | NARI | Nov 22, 2024 | 49.66 | -0.18 |
Incannex Healthcare ADR | IXHL | Nov 22, 2024 | 1.98 | +0.52 |
Inception Growth Acquisition | IGTA | Nov 22, 2024 | 11.75 | +0.60 |
Inception Growth Acquisition Unit | IGTAU | Nov 22, 2024 | 11.60 | 0.00 |
Income Opportunity Realty Investors | IOR | Nov 22, 2024 | 16.01 | -5.82 |
Incyte | INCY | Nov 22, 2024 | 71.72 | +1.89 |
Indaptus Therapeutics | INDP | Nov 22, 2024 | 1.00 | -4.31 |
Independence Realty Trust | IRT | Nov 22, 2024 | 21.75 | +1.26 |
Independent Bank | INDB | Nov 22, 2024 | 73.98 | +2.55 |
Independent Bank | IBCP | Nov 22, 2024 | 38.50 | +2.07 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.